Stock info Coltene | Filter  Basic-Info

Coltene

The past 10 years the (international) industry gained at around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The past year was a profitable year for the Coltene investors

The stock gained over the past 12 months at around 13 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 132 percent. Coltene's revenues between 2011 and 2015 were quite stable and moved between 158,08 million CHFF and 154,5 million CHFF. Coltene's net incomes between 2011 and 2015 were very volatile through the time and moved between 5,98 million CHFF and 13,34 million CHFF.

The Swiss company paid out dividends in the past 5 years. Coltene's dividend return over the period 2011 - 2015 was around 9,8 percent per year.

At the end of 2015 around 1852 thousand people were employed at Coltene.

Coltene financed with a quite low debt position

At the end of 2015 the Swiss company's balance sheet was worth 149,19 million CHFF. The total debt was around 47,61 million CHFF. This is 31,91 percent of the total balance sheet. At the end of 2016 the Swiss company was traded with a price/earnings-ratio of around 20. So investors paid 20 times the company's 2015's EPS. We could say that based on it's price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 261,04 million CHFF. At the end of 2015 the Swiss company had around 4,22 million stocks listed on the exchanges.

All the annual reports of Coltene are available here. More information about Coltene can be found it's website. .